Heublein, S.; Page, S.; Mayr, D.; Schmoeckel, E.; Trillsch, F.; Marmé, F.; Mahner, S.; Jeschke, U.; Vattai, A.
Potential Interplay of the Gatipotuzumab Epitope TA-MUC1 and Estrogen Receptors in Ovarian Cancer. Int. J. Mol. Sci. 2019, 20, 295.
https://doi.org/10.3390/ijms20020295
AMA Style
Heublein S, Page S, Mayr D, Schmoeckel E, Trillsch F, Marmé F, Mahner S, Jeschke U, Vattai A.
Potential Interplay of the Gatipotuzumab Epitope TA-MUC1 and Estrogen Receptors in Ovarian Cancer. International Journal of Molecular Sciences. 2019; 20(2):295.
https://doi.org/10.3390/ijms20020295
Chicago/Turabian Style
Heublein, Sabine, Sabina Page, Doris Mayr, Elisa Schmoeckel, Fabian Trillsch, Frederik Marmé, Sven Mahner, Udo Jeschke, and Aurelia Vattai.
2019. "Potential Interplay of the Gatipotuzumab Epitope TA-MUC1 and Estrogen Receptors in Ovarian Cancer" International Journal of Molecular Sciences 20, no. 2: 295.
https://doi.org/10.3390/ijms20020295
APA Style
Heublein, S., Page, S., Mayr, D., Schmoeckel, E., Trillsch, F., Marmé, F., Mahner, S., Jeschke, U., & Vattai, A.
(2019). Potential Interplay of the Gatipotuzumab Epitope TA-MUC1 and Estrogen Receptors in Ovarian Cancer. International Journal of Molecular Sciences, 20(2), 295.
https://doi.org/10.3390/ijms20020295